>ABOUT TAKEDA >History >History 2000-

History 2000-

Based on the corporate philosophy of "Takeda-ism" (Integrity: Fairness, Honesty and Perseverance) developed over its long corporate history of more than 230 years, Takeda conducts activities according to the corporate mission to "strive towards better health for people worldwide through leading innovation in medicine."

Changes to the Corporate Logo

  • 1781-1944
  • 1945-1984
  • 1985-1999
  • 2000-

2000-

  • 2000

    Divestment of Non-Pharmaceutical Businesses

    In order to concentrate management resources into pharmaceutical businesses...

  • 2002

    Takeda Pharma GmbH Fully Integrated,Takeda Ireland Limited Established

    Takeda Pharma GmbH and its two wholly owned subsidiaries, Takeda Pharma ...

  • 2005

    Integration of Syrrx, Inc.

  • 1995

    Rozerem Launched in the U.S.

  • 2006

    Takeda Pharmaceuticals Europe Limited Established in U.K.

  • 2006

    Completion of New Offices in the U.S.

  • 2006

    CSR Report Integrated into the Annual Report

  • 2007

    Integration of Paradigm Therapeutics Limited

    Through the integration of Paradigm Therapeutics and its subsidiary in Singapore...

  • 2008

    Integration of TAP Pharmaceutical Products, Inc.

    Through this integration, Takeda reinforced its marketing and development functions...

  • 2008

    Integration of Millennium Pharmaceuticals, Inc.

  • 2008

    Takeda Pharmaceuticals (Asia Pacific) Pte. Limited and Takeda Clinical Research Singapore...

  • 2009

    Dexilant Launched in the U.S.

  • 2009

    Uloric Launched in the U.S.

  • 2009

    Participated in the United Nations Global Compact...

    Takeda supports the United Nations Global Compact's 10 principles relating to...

  • 2010

    "Takeda Initiative" Launched

  • 2010

    Takeda Global Code of Conduct Formulated

    Takeda instituted the Takeda Global Code of Conduct as a baseline standard...

  • 1995

    Azilva Launched in Japan

  • 2011

    Shonan Research Center Established

  • 2011

    Integration of Nycomed

  • 2011

    United Nations Global Compact LEAD Program Participation

  • 2011

    Support for Japan's Vitality and Recovery

  • 2012

    Global Vaccine Business Established

  • 2012

    Integration of 4 Companies

    ・URL Pharma, Inc.: Added the leading product Colcrys (colchicine) to our portfolio for the treatment...

  • 2012

    Global EHS Policy Formulated

    Takeda established a global policy on Environment, Health, and Safety, and promoted comprehensive initiatives・・・

  • 2012

    Adcetris Launched in Europe

  • 2013

    Lotriga Launched in Japan

  • 2013

    Nesina Launched in the U.S.

  • 2013

    Women's Empowerment Principles (WEPs) Supported

  • 2013

    Integration of Inviragen

    Through the integration of Inviragen, Inc. (based in Colorado, U.S.), we acquired...

  • 2013

    Trintellix Launched in the US

  • 2014

    Entyvio Launched in Europe and the US

    Entyvio is a groundbreaking new product that offers a new treatment option to patients...

  • 2013

    NINLARO® Launched in the US